RxDoctor Payments DataLook up a doctor →

M Lauter, MD

Family Medicine · Portsmouth, NHNPI 1366544819

Payments from drug & device makers

$21,438in general payments, 2019–2025

Across 1,064 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • AbbVie$3K
  • Boehringer Ingelheim$2K
  • GSK$2K
  • Pfizer$1K
  • Amgen$1K
  • plus $9K from 49 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)137$3,626
AbbVie(2 entities)167$2,812
Boehringer Ingelheim99$1,871
GSK66$1,805
Pfizer82$1,206
Amgen56$1,088
Merck54$975
Novo Nordisk49$881
Lilly USA, LLC44$810
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC35$766
Axsome Therapeutics, Inc.22$627
Astellas Pharma US Inc22$498
Johnson & Johnson25$437
Takeda Pharmaceuticals U.S.A., Inc.19$320
Teva Pharmaceuticals USA, Inc.5$316
Bayer13$296
Amarin Pharma, Inc.16$234
Corium, LLC13$232
Novartis12$221
Exact Sciences12$200
Daiichi Sankyo Inc.9$194
Radius Health, Inc.9$167
Phathom Pharmaceuticals, Inc.9$153
Abbott8$144
Sanofi Pasteur Inc.6$139
Biohaven Pharmaceuticals, Inc.4$137
Genentech USA, Inc.6$118
E.r. Squibb & Sons, L.L.C.6$108
Seqirus USA Inc5$82
Boston Scientific4$79
Esperion Therapeutics, Inc.5$78
Dexcom, Inc.2$61
Verona Pharma, Inc.3$60
Sanofi-aventis U.S. LLC4$56
Circassia Inc.4$54
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$54
Biodelivery Sciences International, Inc.3$48
Aimmune Therapeutics, Inc.2$45
Shield Therapeutics Inc2$40
Halozyme Inc2$39
Otsuka America Pharmaceutical, Inc.2$39
Shire North American Group Inc2$38
Collegium Pharmaceutical, Inc.2$36
Sumitomo Pharma America, Inc.2$30
Medline Industries LP1$29
Ironshore Pharmaceuticals Inc.2$28
Edwards Lifesciences1$23
Antares Pharma, Inc.1$23
Bristol Myers Squibb1$19
Ultragenyx Pharmaceutical Inc.1$18
Inspire Medical Systems, Inc.1$18
Biohaven Pharmaceutical Holding Company Ltd.1$17
Medtronic1$17
Kiniksa Pharmaceuticals International, PLC1$14
Corcept Therapeutics1$13

How this compares

$21,438 in reported general payments places this provider in the 95th percentile of 397 family medicine providers in New Hampshire.

See all family medicine providers in New Hampshire →

Medicare billing

Part B allowed, 2024
$92,644
Medicare patients
159
Services billed
998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Portsmouth

See the full list for New Hampshire →

Where these figures come from

Is this you, or does something look wrong? →